These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3861612)

  • 1. Proposed disk diffusion susceptibility criteria for ofloxacin.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1985 Aug; 22(2):310-1. PubMed ID: 3861612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of proposed criteria of disk susceptibility testing for tosufloxacin and lomefloxacin in NCCLS guidelines and WHO standards].
    Aihara M; Oguri T; Kanno H; Kubo S; Honda M; Satoh K; Daimon Y; Yamanaka K; Sugawara K; Furuta T
    Rinsho Byori; 1992 Jan; 40(1):73-80. PubMed ID: 1312183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Criteria for the interpretation of sensitivity testing of ofloxacin with the agar diffusion test].
    Grimm H
    Infection; 1986; 14 Suppl 1():S16-9. PubMed ID: 3456982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disk susceptibility of ofloxacin, a new carboxyquinolone.
    Mandell W; Neu HC
    J Clin Microbiol; 1985 Nov; 22(5):786-8. PubMed ID: 3863833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ofloxacin susceptibility testing quality control parameters for microdilution and disk diffusion, and confirmation of disk diffusion interpretive criteria.
    Fuchs PC; Jones RN; Barry AL; Gavan TL
    J Clin Microbiol; 1989 Jan; 27(1):49-52. PubMed ID: 2492304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretive criteria for the agar diffusion susceptibility test with ofloxacin.
    Grimm H
    Drugs; 1987; 34 Suppl 1():14-9. PubMed ID: 3481315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks.
    Jones RN; Erwin ME; Barrett MS
    Diagn Microbiol Infect Dis; 1992; 15(4):379-81. PubMed ID: 1319303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefoperazone: regression analysis, disk content, and disk susceptibility testing considerations.
    Wright DN; Welch DF; Saxon BA; Clark SJ; Matsen JM
    Antimicrob Agents Chemother; 1982 Sep; 22(3):493-8. PubMed ID: 6215895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial activity and susceptibility testing of ofloxacin. Current status.
    Fuchs PC
    Am J Med; 1989 Dec; 87(6C):10S-13S. PubMed ID: 2690614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.
    Fuchs PC; Jones RN; Barry AL
    J Clin Microbiol; 1990 Mar; 28(3):608-9. PubMed ID: 2108997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
    Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P
    Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefixime disk susceptibility test criteria.
    Fuchs PC; Barry AL; Jones RN
    J Clin Microbiol; 1986 Oct; 24(4):647-9. PubMed ID: 3771755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of amifloxacin and five other fluoroquinolone antimicrobial agents and preliminary criteria for the disk susceptibility test.
    Barry AL; Jones RN
    Eur J Clin Microbiol; 1987 Apr; 6(2):179-82. PubMed ID: 3474145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aztreonam: correlation between disk diffusion and agar plate dilutions susceptibility tests.
    Toma EC; Morisset R; Phaneuf D; Poisson M
    Chemotherapy; 1985; 31(6):451-5. PubMed ID: 4075858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L; Biedenbach DJ; Jones RN
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1980 Jul; 18(1):88-93. PubMed ID: 6251750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.
    Fuchs PC; Barry AL; Baker C; Murray PR; Washington JA
    J Clin Microbiol; 1992 Apr; 30(4):1024-6. PubMed ID: 1572960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of quinolone-resistant Neisseria gonorrhoeae.
    Kam KM; Wong PW; Cheung MM; Ho NK
    J Clin Microbiol; 1996 Jun; 34(6):1462-4. PubMed ID: 8735098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.